Skip to main content

Advertisement

Table 1 Baseline characteristics of patients in curcumin group and placebo group

From: The effect of curcumin supplementation on anthropometric indices, insulin resistance and oxidative stress in patients with type 2 diabetes: a randomized, double-blind clinical trial

Variable Curcumin group Placebo group P value
Sex (%)
 Male 61.6 39.1 0.2
 Female 38.4 60.9
Smoking (%) 19 13 0.4
Age (years) 58 ± 8 60 ± 7 0.09
Duration of diabetes (years) 8 ± 4.6 8 ± 7.9 0.7
Anti-hyperglycemic drugs metformin 52% 43% 0.8
Gelibenclamide 52% 43%
Gelibenclamide + metformin 33% 35%
Non 10% 17%
Anti-hyperlipidemic drugs 47.6% 52.2% 0.6
Anti-hypertensive drugs 66.7% 65.2% 0.5
  1. P values are for comparison of variable between curcumin and placebo group (all by Chi square analyzed except age and duration of diabetes which were analyzed by t-independent test, p: 0.05)